Company Data

Pulse Biosciences Inc

Ticker
PLSE
Current Price
$20 -1.33%
Market Cap
$1.2B
Price Target
Refer to Report
Volume
119.1K
52wk Range
$6.595 - $25
Advanced Market Data

Overview

Pulse Biosciences Inc is a United States based clinical stage medical therapy company which pursues the commercial introduction of its proprietary CellFX System utilizing its patent-protected Nano-Pulse Stimulation (NPS) platform technology. Through its proprietary CellFX System, the company can deliver a cell-focused effect on dysfunctional cells while preserving surrounding non-cellular tissue, a combination that may potentially lead to both improved efficacy and less collateral tissue damage.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy